IONOJET Trademark

Trademark Overview

On Friday, March 15, 2019, a trademark application was filed for IONOJET with the United States Patent and Trademark Office. The USPTO has given the IONOJET trademark a serial number of 88342025. The federal status of this trademark filing is REGISTERED as of Tuesday, October 25, 2022. This trademark is owned by Origin, Inc.. The IONOJET trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceutical for the treatment of damaged skin and tissue; Therapeutic pharmaceutical for the treatment of infectious diseases, pain, inflammation, sepsis, obesity and cognitive disorders; Therapeutic pharmaceutical for the treatment of viral metabolic endocrine musculoskeletal cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, psychiatric, and immune system related disease and disorders; Therapeutic pharmaceutical for the treatment of pulmonary hypertension via inhalation; Therapeutic pharmaceutical for the treatment of ocular disorders or diseases, bacteria based diseases, diabetes related complications, anti-infective preparations, antiviral preparations, antibiotics, and vaccines; Therapeutic pharmaceutical for the treatment of tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Therapeutic pharmaceutical for the treat...
ionojet

General Information

Serial Number88342025
Word MarkIONOJET
Filing DateFriday, March 15, 2019
Status700 - REGISTERED
Status DateTuesday, October 25, 2022
Registration Number6885177
Registration DateTuesday, October 25, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2019

Trademark Statements

Goods and ServicesTherapeutic pharmaceutical for the treatment of damaged skin and tissue; Therapeutic pharmaceutical for the treatment of infectious diseases, pain, inflammation, sepsis, obesity and cognitive disorders; Therapeutic pharmaceutical for the treatment of viral metabolic endocrine musculoskeletal cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, psychiatric, and immune system related disease and disorders; Therapeutic pharmaceutical for the treatment of pulmonary hypertension via inhalation; Therapeutic pharmaceutical for the treatment of ocular disorders or diseases, bacteria based diseases, diabetes related complications, anti-infective preparations, antiviral preparations, antibiotics, and vaccines; Therapeutic pharmaceutical for the treatment of tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Therapeutic pharmaceutical for the treatment of wounds

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 4, 2019
Primary Code005
First Use Anywhere DateMonday, February 28, 2022
First Use In Commerce DateMonday, February 28, 2022

Trademark Owner History

Party NameORIGIN LIFE SCIENCES, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPRINCETON, NJ 08540
Party NameOrigin, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameOrigin, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameOrigin, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Wednesday, September 13, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 25, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 25, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 20, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, September 17, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 25, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 23, 2022USE AMENDMENT FILED
Tuesday, August 23, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, March 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 1, 2022SOU EXTENSION 5 GRANTED
Wednesday, February 23, 2022SOU EXTENSION 5 FILED
Wednesday, February 23, 2022SOU TEAS EXTENSION RECEIVED
Saturday, August 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 26, 2021SOU EXTENSION 4 GRANTED
Thursday, August 26, 2021SOU EXTENSION 4 FILED
Thursday, August 26, 2021SOU TEAS EXTENSION RECEIVED
Friday, February 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 26, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 26, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 24, 2021SOU EXTENSION 3 GRANTED
Wednesday, February 24, 2021SOU EXTENSION 3 FILED
Wednesday, February 24, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 24, 2020SOU EXTENSION 2 GRANTED
Monday, August 24, 2020SOU EXTENSION 2 FILED
Monday, August 24, 2020SOU TEAS EXTENSION RECEIVED
Thursday, April 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 22, 2020SOU EXTENSION 1 GRANTED
Thursday, February 27, 2020SOU EXTENSION 1 FILED
Wednesday, April 22, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, April 5, 2020NOTICE OF REVIVAL - E-MAILED
Friday, April 3, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, April 3, 2020PETITION TO REVIVE-GRANTED
Friday, April 3, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, March 30, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 30, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 27, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 24, 2019ASSIGNED TO EXAMINER
Thursday, April 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 19, 2019NEW APPLICATION ENTERED

Related Keywords

ionojet pharmaceutical therapeutic treatment disorders diseases related injuries preparations complications based